バイオインフォマティクス市場 : 2027 年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2022年12月

バイオインフォマティクス市場 : 製品とサービス (知識管理ツール、バイオインフォマティクスプラットフォーム、データ分析、構造分析、サービス)、用途 (ゲノミクス、プロテオミクス、トランスクリプトミクス)、セクター (医療、動物) – 2027 年までの世界予測
Bioinformatics Market by Product & Service (Knowledge Management Tools, Bioinformatics Platforms, Data Analysis, Structural Analysis, Services), Applications (Genomics, Proteomics, Transcriptomics), & Sectors (Medical, Animal) – Global Forecast to 2027

ページ数226
図表数257
種別英文調査報告書
価格

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

The global bioinformatics market was valued at USD 10.1 Billion in 2022 and is projected to reach USD 18.7 Billion by 2027, at a CAGR of 13.0% during the forecast period. The growth of the bioinformatics market is driven by the increasing public and private-sector funding for bioinformatics, growing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure, and decreasing cost of genome sequencing. However, the high cost of equipment is hindering the growth of this market.

バイオインフォマティクス市場 : 製品とサービス (知識管理ツール、バイオインフォマティクスプラットフォーム、データ分析、構造分析、サービス)、用途 (ゲノミクス、プロテオミクス、トランスクリプトミクス)、セクター (医療、動物) - 2027 年までの世界予測 Bioinformatics Market by Product & Service (Knowledge Management Tools, Bioinformatics Platforms, Data Analysis, Structural Analysis, Services), Applications (Genomics, Proteomics, Transcriptomics), & Sectors (Medical, Animal) - Global Forecast to 2027

“Bioinformatics services segment is estimated to be the fastest-growing segment during the forecast period”
Based on product & service, the bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services. In 2021, the knowledge management tools segment accounted for the largest share of 36.3% of the bioinformatics market. The large share of this segment is attributed to the growing demand for knowledge management tools to manage large volumes of data generated in life science research and drug discovery. However, the bioinformatics services segment is estimated to be the fastest-growing segment during the forecast period. The need to reduce sequencing costs and manage growing data volumes, as well as the growing government funding for genomics research, are responsible for the growth of this market segment.

Medical biotechnology to hold the largest segment of the market
Based on the sector, the market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, an dother sectors . The medical biotechnology segment accounted for the largest share of 50.3% of the bioinformatics market in 2021. The new databases for drug discovery, the application of bioinformatics for clinical diagnostics, and the increased funding opportunities to launch bioinformatics solutions for clinical diagnostics are major factors driving the growth of the medical biotechnology segment in the market.

Genomics segment to hold the largest share of the component market
Based on application, the bioinformatics market is segmented into genomics, chemoinformatics & drug design, proteomics, transcripomics, metabolomics, and other applications. The genomics segment accounted for the largest market share of 36.9% in 2021. The increasing use of pharmacogenomic research for the development of precision medicine, the growing favorable funding scenario for genomic research, and the increasing partnerships and collaborations between various life sciences and informatics companies for the development of advanced bioinformatics tools and software are the major factors contributing to the growth of the bioinformatics market for genomics.

The US to dominate the bioinformatics market in North America
North America dominated the bioinformatics market, with a share of 45.1% in 2021, followed by Europe and the Asia Pacific, and Rest of World. North America has been among the frontrunners in developing bioinformatics services in the healthcare industry. The bioinformatics market in the US is expected to offer growth opportunities in the coming years owing to the increasing incorporation of EHR in the hospitals. Many major global players are also based in the US, owing to which the country has become a center of innovation in the bioinformatics market.

Breakdown of supply-side primary interviews: • By Company Type: Tier 1 – 45%, Tier 2 – 40%, and Tier 3 – 15% • By Designation: Director-level – 30%, C-level – 41%, and Others – 29% • By Region: North America – 36%, Europe – 30%, APAC –21%, Rest of the World –13%
Some of the prominent players operating in the bioinformatics market are Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China) Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.

バイオインフォマティクス市場 : 製品とサービス (知識管理ツール、バイオインフォマティクスプラットフォーム、データ分析、構造分析、サービス)、用途 (ゲノミクス、プロテオミクス、トランスクリプトミクス)、セクター (医療、動物) - 2027 年までの世界予測 Bioinformatics Market by Product & Service (Knowledge Management Tools, Bioinformatics Platforms, Data Analysis, Structural Analysis, Services), Applications (Genomics, Proteomics, Transcriptomics), & Sectors (Medical, Animal) - Global Forecast to 2027

Research Coverage
This report studies the bioinformatics market based on products & services, sector, and application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to two main geographies – source and destination.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.


目次

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.3 MARKET SCOPE 32
1.3.1 INCLUSIONS AND EXCLUSIONS 32
1.3.2 MARKETS COVERED 32
1.3.3 YEARS CONSIDERED 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 RESEARCH DESIGN 35
2.1.1 SECONDARY SOURCES 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY SOURCES 37
FIGURE 2 PRIMARY SOURCES 37
2.1.2.1 Key data from primary sources 38
FIGURE 3 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 38
2.2 MARKET SIZE ESTIMATION 39
FIGURE 4 BIOINFORMATICS MARKET: REVENUE MAPPING-BASED MARKET ESTIMATION (BOTTOM-UP APPROACH) 39
FIGURE 5 BIOINFORMATICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 40
FIGURE 6 CAGR PROJECTIONS: BIOINFORMATICS MARKET 41
FIGURE 7 BIOINFORMATICS MARKET: TOP-DOWN APPROACH 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 8 DATA TRIANGULATION METHODOLOGY 42
2.4 ASSUMPTIONS 43
2.5 RISK ANALYSIS 43
3 EXECUTIVE SUMMARY 44
FIGURE 9 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2027 (USD MILLION) 44
FIGURE 10 BIOINFORMATICS MARKET, BY SECTOR, 2021 VS. 2027 (USD MILLION) 45
FIGURE 11 BIOINFORMATICS MARKET, BY APPLICATION, 2021 VS. 2027 (USD MILLION) 45
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF BIOINFORMATICS MARKET 46
4 PREMIUM INSIGHTS 47
4.1 BIOINFORMATICS MARKET OVERVIEW 47
FIGURE 13 INCREASING PUBLIC AND PRIVATE-SECTOR FUNDING FOR BIOINFORMATICS TO DRIVE MARKET GROWTH DURING FORECAST PERIOD 47
4.2 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE AND REGION 48
FIGURE 14 KNOWLEDGE MANAGEMENT TOOLS SEGMENT TO DOMINATE BIOINFORMATICS MARKET DURING FORECAST PERIOD 48
4.3 BIOINFORMATICS MARKET: GROWTH RATE SNAPSHOT, BY COUNTRY 48
FIGURE 15 INDIA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 48
4.4 BIOINFORMATICS MARKET: REGIONAL MIX 49
FIGURE 16 NORTH AMERICA DOMINATED MARKET IN 2021 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
FIGURE 17 BIOINFORMATICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.1.1 DRIVERS 50
5.1.1.1 Increasing public and private-sector funding for bioinformatics 50
TABLE 1 PUBLIC AND PRIVATE-SECTOR FUNDING FOR BIOINFORMATICS AND RELATED FIELDS 51
5.1.1.2 Growing demand for personalized medicine 52
5.1.1.3 Increasing pharmaceutical and biotechnology R&D expenditure 53
TABLE 2 R&D INVESTMENTS BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN ASIA PACIFIC REGION 53
5.1.1.4 Decreasing cost of genome sequencing 53
5.1.2 RESTRAINTS 54
5.1.2.1 High cost of equipment 54
5.1.3 OPPORTUNITIES 55
5.1.3.1 Lucrative opportunities in emerging markets 55
5.1.3.2 Adoption of blockchain technology and cloud computing 55
5.1.3.3 Integration of machine learning and AI in healthcare 56
5.1.3.4 Investments by leading IT companies in development of bioinformatics solutions 56
5.1.4 CHALLENGES 57
5.1.4.1 Management of large data volumes 57
5.1.4.2 Lack of interoperability and multiplatform capabilities 57
5.1.4.3 Growing competition from in-house development and publicly available tools 58
5.1.4.4 Shortage of skilled bioinformatics professionals 58
5.2 PORTER’S FIVE FORCES ANALYSIS 59
5.2.1 THREAT OF NEW ENTRANTS 59
5.2.2 BARGAINING POWER OF SUPPLIERS 59
5.2.3 BARGAINING POWER OF BUYERS 59
5.2.4 THREAT OF SUBSTITUTES 59
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 59
5.3 VALUE CHAIN ANALYSIS 60
FIGURE 18 VALUE CHAIN ANALYSIS: BIOINFORMATICS MARKET 60
5.3.1 RESEARCH AND DEVELOPMENT (R&D) 60
5.3.2 RAW MATERIALS 60
5.3.3 DISTRIBUTION AND AFTER-SALES SERVICES 60
5.4 REGULATORY LANDSCAPE 61
5.4.1 NORTH AMERICA 61
5.4.2 EUROPE 62
5.4.3 ASIA PACIFIC 62
5.4.4 MIDDLE EAST & AFRICA 63
5.4.5 LATIN AMERICA 63
5.5 CASE STUDIES 63
5.6 ECOSYSTEM/MARKET MAP 64
FIGURE 19 BIOINFORMATICS ECOSYSTEM 64
5.7 TECHNOLOGY ANALYSIS 64
TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS 64
5.8 INDUSTRY TRENDS 65
5.8.1 DISCOVERY OF BIOMARKERS 65
5.8.2 PROTEIN INTERACTIONS AND PATHWAYS 65
5.8.3 GENETIC INTERACTION DUE TO HUMAN DISEASES 65
5.9 PRICING ANALYSIS 65
TABLE 4 AVERAGE SELLING PRICE OF BIOINFORMATICS SOLUTIONS, BY PRODUCT 66
TABLE 5 AVERAGE SELLING PRICE OF BIOINFORMATICS SOLUTIONS, BY SERVICE 66
5.10 KEY CONFERENCES AND EVENTS 66
TABLE 6 BIOINFORMATICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 66
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 67
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 67
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS AMONG END USERS 67
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS AMONG END USERS 67
5.11.2 BUYING CRITERIA 68
FIGURE 21 KEY BUYING CRITERIA FOR END USERS 68
TABLE 8 KEY BUYING CRITERIA FOR END USERS 68
6 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE 69
6.1 INTRODUCTION 70
TABLE 9 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 70
6.2 KNOWLEDGE MANAGEMENT TOOLS 70
TABLE 10 KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 11 KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION, 2020–2027 (USD MILLION) 71
TABLE 12 NORTH AMERICA: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 71
TABLE 13 EUROPE: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 72
TABLE 14 APAC: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 72
6.2.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 72
6.2.1.1 Development of novel generalized knowledge management tools to drive growth 72
TABLE 15 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION, 2020–2027 (USD MILLION) 73
6.2.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 73
6.2.2.1 Data security and highly reliable information storage systems to support growth 73
TABLE 16 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION, 2020–2027 (USD MILLION) 74
6.3 BIOINFORMATICS PLATFORMS 74
TABLE 17 BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 18 BIOINFORMATICS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 75
TABLE 19 NORTH AMERICA: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 75
TABLE 20 EUROPE: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 75
TABLE 21 APAC: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76
6.3.1 DATA ANALYSIS PLATFORMS 76
6.3.1.1 Increasing need for data analysis during sequencing programs to drive growth 76
TABLE 22 DATA ANALYSIS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 76
6.3.2 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS 77
6.3.2.1 Growing proteomics research worldwide to drive growth 77
TABLE 23 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 77
6.3.3 OTHER BIOINFORMATICS PLATFORMS 77
TABLE 24 OTHER BIOINFORMATICS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 78
6.4 BIOINFORMATICS SERVICES 78
TABLE 25 BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 26 BIOINFORMATICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 79
TABLE 27 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 79
TABLE 28 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
TABLE 29 APAC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
6.4.1 SEQUENCING SERVICES 80
6.4.1.1 Financial support from government and private bodies to drive growth 80
TABLE 30 SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 81
TABLE 31 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 81
TABLE 32 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 81
TABLE 33 APAC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 82
6.4.2 DATA ANALYSIS SERVICES 82
6.4.2.1 Growing adoption of big data analytics in life science research to drive growth 82
TABLE 34 DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 83
TABLE 35 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
TABLE 36 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
TABLE 37 APAC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4.3 DRUG DISCOVERY SERVICES 84
6.4.3.1 Growing technological advancements in pharmacogenomics to drive growth 84
TABLE 38 DRUG DISCOVERY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 84
TABLE 39 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 40 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 41 APAC: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
6.4.4 DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES 86
6.4.4.1 Increasing R&D for advancement of solutions and services for differential gene expression studies to drive growth 86
TABLE 42 DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION) 86
TABLE 43 NORTH AMERICA: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86
TABLE 44 EUROPE: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
TABLE 45 APAC: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.4.5 DATABASE AND MANAGEMENT SERVICES 87
6.4.5.1 Growing volume of data generated to increase need for database and management services 87
TABLE 46 DATABASE AND MANAGEMENT SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 88
TABLE 47 NORTH AMERICA: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88
TABLE 48 EUROPE: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88
TABLE 49 APAC: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
6.4.6 OTHER BIOINFORMATICS SERVICES 89
TABLE 50 OTHER BIOINFORMATICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 89
TABLE 51 NORTH AMERICA: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
TABLE 52 EUROPE: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 53 APAC: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
7 BIOINFORMATICS MARKET, BY APPLICATION 91
7.1 INTRODUCTION 92
TABLE 54 BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 92
7.2 GENOMICS 92
7.2.1 DECREASING COST OF NEXT-GENERATION SEQUENCING TO BOOST GROWTH 92
TABLE 55 GENOMICS MARKET, BY REGION, 2020–2027 (USD MILLION) 93
7.3 CHEMOINFORMATICS & DRUG DESIGN 93
7.3.1 GROWING USE IN DRUG DESIGNING PROCESS BY PHARMACEUTICAL COMPANIES TO DRIVE GROWTH 93
TABLE 56 CHEMOINFORMATICS & DRUG DESIGN MARKET, BY REGION, 2020–2027 (USD MILLION) 93
7.4 PROTEOMICS 94
7.4.1 INCREASING APPLICATIONS IN DRUG DISCOVERY TO DRIVE GROWTH 94
TABLE 57 PROTEOMICS MARKET, BY REGION, 2020–2027 (USD MILLION) 94
7.5 TRANSCRIPTOMICS 95
7.5.1 TRANSCRIPTOMICS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 95
TABLE 58 TRANSCRIPTOMICS MARKET, BY REGION, 2020–2027 (USD MILLION) 95
7.6 METABOLOMICS 95
7.6.1 INCREASING RESEARCH FUNDING TO DRIVE GROWTH 95
TABLE 59 METABOLOMICS MARKET, BY REGION, 2020–2027 (USD MILLION) 96
7.7 OTHER APPLICATIONS 96
TABLE 60 OTHER APPLICATIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 96
8 BIOINFORMATICS MARKET, BY SECTOR 97
8.1 INTRODUCTION 98
TABLE 61 BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 98
8.2 MEDICAL BIOTECHNOLOGY 98
TABLE 62 BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY SECTOR, 2020–2027 (USD MILLION) 99
TABLE 63 BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 99
TABLE 64 NORTH AMERICA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 65 EUROPE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 100
TABLE 66 APAC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 100
8.2.1 DRUG DISCOVERY & DEVELOPMENT 100
8.2.1.1 Increasing adoption of bioinformatics services and products for drug designing to drive growth 100
TABLE 67 BIOINFORMATICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION) 101
8.2.2 CLINICAL DIAGNOSTICS & PERSONALIZED MEDICINE 101
8.2.2.1 Focus on development of bioinformatics tools for personalized medicine to propel growth 101
TABLE 68 BIOINFORMATICS MARKET FOR CLINICAL DIAGNOSTICS & PERSONALIZED MEDICINE, BY REGION, 2020–2027 (USD MILLION) 102
8.2.3 REPRODUCTIVE HEALTH 102
8.2.3.1 Increasing R&D on reproductive health to bolster market growth 102
TABLE 69 BIOINFORMATICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2020–2027 (USD MILLION) 103
8.3 ANIMAL BIOTECHNOLOGY 103
8.3.1 RAPID ADVANCES IN UNDERSTANDING OF FARM ANIMAL GENOMES TO AID MARKET GROWTH 103
TABLE 70 BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 71 NORTH AMERICA: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 104
TABLE 72 EUROPE: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 104
TABLE 73 APAC: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 105
8.4 PLANT BIOTECHNOLOGY 105
8.4.1 INCREASED USE OF BIOINFORMATICS FOR TIME AND COST-EFFICIENT R&D IN AGRICULTURE TO DRIVE MARKET GROWTH 105
TABLE 74 BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 106
TABLE 75 NORTH AMERICA: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 76 EUROPE: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 107
TABLE 77 APAC: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 107
8.5 ENVIRONMENTAL BIOTECHNOLOGY 107
8.5.1 INCREASING USE OF NGS FOR ENVIRONMENTAL BIOTECHNOLOGY APPLICATIONS TO DRIVE MARKET GROWTH 107
TABLE 78 BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 108
TABLE 79 NORTH AMERICA: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 80 EUROPE: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 81 APAC: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 109
8.6 FORENSIC BIOTECHNOLOGY 109
8.6.1 INCREASING AVAILABILITY OF ADVANCED SOFTWARE FOR INVESTIGATIONAL PURPOSES TO DRIVE GROWTH 109
TABLE 82 BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 109
TABLE 83 NORTH AMERICA: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 84 EUROPE: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 85 APAC: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 110
8.7 OTHER SECTORS 111
TABLE 86 BIOINFORMATICS MARKET FOR OTHER SECTORS, BY REGION, 2020–2027 (USD MILLION) 112
TABLE 87 NORTH AMERICA: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 88 EUROPE: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 89 APAC: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 113
9 BIOINFORMATICS MARKET, BY REGION 114
9.1 INTRODUCTION 115
TABLE 90 BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION) 115
9.2 NORTH AMERICA 115
FIGURE 22 NORTH AMERICA: BIOINFORMATICS MARKET SNAPSHOT (2021) 116
TABLE 91 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 92 NORTH AMERICA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 117
TABLE 93 NORTH AMERICA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 94 NORTH AMERICA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 95 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 96 NORTH AMERICA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 119
TABLE 97 NORTH AMERICA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 98 NORTH AMERICA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119
9.2.1 US 120
9.2.1.1 US dominated North American market in 2021 120
TABLE 99 US: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 120
TABLE 100 US: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 101 US: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 102 US: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 103 US: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 122
TABLE 104 US: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 105 US: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122
9.2.2 CANADA 123
9.2.2.1 Growth in genomics field to drive market 123
TABLE 106 CANADA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 123
TABLE 107 CANADA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 108 CANADA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 109 CANADA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 110 CANADA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 125
TABLE 111 CANADA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 112 CANADA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 125
9.3 EUROPE 126
FIGURE 23 EUROPE: BIOINFORMATICS MARKET SNAPSHOT (2021) 127
TABLE 113 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 114 EUROPE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 128
TABLE 115 EUROPE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 116 EUROPE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 117 EUROPE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 118 EUROPE: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 130
TABLE 119 EUROPE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 120 EUROPE: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130
9.3.1 GERMANY 131
9.3.1.1 Germany expected to be largest market for bioinformatics products and services in Europe 131
TABLE 121 GERMANY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 131
TABLE 122 GERMANY: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 123 GERMANY: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 124 GERMANY: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 125 GERMANY: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 133
TABLE 126 GERMANY: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 133
TABLE 127 GERMANY: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 133
9.3.2 UK 134
9.3.2.1 Increasing genomics research to drive market growth 134
TABLE 128 UK: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134
TABLE 129 UK: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 130 UK: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 131 UK: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 132 UK: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 136
TABLE 133 UK: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 134 UK: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 136
9.3.3 FRANCE 137
9.3.3.1 Government initiatives for genomics research to drive market growth 137
TABLE 135 FRANCE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 137
TABLE 136 FRANCE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 137 FRANCE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 138 FRANCE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 139 FRANCE: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 139
TABLE 140 FRANCE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 141 FRANCE: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
9.3.4 ITALY 140
9.3.4.1 Increasing research in genomics to drive market growth 140
TABLE 142 ITALY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 140
TABLE 143 ITALY: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 144 ITALY: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 145 ITALY: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 146 ITALY: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 142
TABLE 147 ITALY: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 148 ITALY: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
9.3.5 SPAIN 143
9.3.5.1 Presence of several local players in Spanish bioinformatics market to drive growth 143
TABLE 149 SPAIN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 143
TABLE 150 SPAIN: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 151 SPAIN: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 152 SPAIN: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 153 SPAIN: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 145
TABLE 154 SPAIN: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 155 SPAIN: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
9.3.6 REST OF EUROPE 146
TABLE 156 ROE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 146
TABLE 157 ROE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 158 ROE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 159 ROE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 160 ROE: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 148
TABLE 161 ROE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 162 ROE: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 148
9.4 ASIA PACIFIC 149
FIGURE 24 ASIA PACIFIC: BIOINFORMATICS MARKET SNAPSHOT (2021) 149
TABLE 163 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 164 ASIA PACIFIC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 150
TABLE 165 ASIA PACIFIC: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 166 ASIA PACIFIC: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 167 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 168 ASIA PACIFIC: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 152
TABLE 169 ASIA PACIFIC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 170 ASIA PACIFIC: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152
9.4.1 CHINA 153
9.4.1.1 Partnerships and collaborations between various industry stakeholders driving development of bioinformatics 153
TABLE 171 CHINA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 153
TABLE 172 CHINA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 173 CHINA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 174 CHINA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 175 CHINA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 155
TABLE 176 CHINA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 177 CHINA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
9.4.2 JAPAN 156
9.4.2.1 Growing focus of Japanese bioinformatics firms on product launches and collaborations to drive growth 156
TABLE 178 JAPAN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 156
TABLE 179 JAPAN: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 180 JAPAN: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 181 JAPAN: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 182 JAPAN: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 158
TABLE 183 JAPAN: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 184 JAPAN: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
9.4.3 INDIA 159
9.4.3.1 Increasing outsourcing of pharmaceutical drug discovery to drive growth 159
TABLE 185 INDIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 159
TABLE 186 INDIA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 187 INDIA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 188 INDIA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 189 INDIA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 161
TABLE 190 INDIA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 191 INDIA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 161
9.4.4 REST OF ASIA PACIFIC 162
TABLE 192 ROAPAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 162
TABLE 193 ROAPAC: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 194 ROAPAC: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 195 ROAPAC: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 196 ROAPAC: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 164
TABLE 197 ROAPAC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 198 ROAPAC: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 164
9.5 REST OF THE WORLD 165
TABLE 199 ROW: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 165
TABLE 200 ROW: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 201 ROW: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 202 ROW: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 203 ROW: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 167
TABLE 204 ROW: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 205 ROW: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 167
10 COMPETITIVE LANDSCAPE 168
10.1 INTRODUCTION 168
10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN 168
TABLE 206 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS 168
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 170
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN BIOINFORMATICS MARKET 170
10.4 MARKET RANKING ANALYSIS, 2021 170
FIGURE 26 RANK OF COMPANIES IN GLOBAL BIOINFORMATICS MARKET, 2021 170
10.5 COMPETITIVE LEADERSHIP MAPPING 171
10.5.1 STARS 171
10.5.2 PERVASIVE PLAYERS 171
10.5.3 EMERGING LEADERS 172
10.5.4 PARTICIPANTS 172
FIGURE 27 BIOINFORMATICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 172
10.6 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES (2021) 173
10.6.1 PROGRESSIVE COMPANIES 173
10.6.2 STARTING BLOCKS 173
10.6.3 RESPONSIVE COMPANIES 173
10.6.4 DYNAMIC COMPANIES 173
FIGURE 28 BIOINFORMATICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021 174
10.7 COMPETITIVE BENCHMARKING 174
TABLE 207 FOOTPRINT OF COMPANIES 175
TABLE 208 PRODUCT & SERVICE FOOTPRINT OF COMPANIES 175
TABLE 209 REGIONAL FOOTPRINT OF COMPANIES 176
10.8 COMPETITIVE SCENARIO 176
10.8.1 PRODUCT & SERVICE LAUNCHES 176
TABLE 210 BIOINFORMATICS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2019–NOVEMBER 2022 176
10.8.2 DEALS 177
TABLE 211 BIOINFORMATICS MARKET: DEALS, JANUARY 2019–NOVEMBER 2022 177
11 COMPANY PROFILES 182
11.1 KEY PLAYERS 182
(Business overview, Products & services offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats)*
11.1.1 THERMO FISHER SCIENTIFIC, INC. 182
TABLE 212 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 182
FIGURE 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021) 183
11.1.2 EUROFINS SCIENTIFIC 189
TABLE 213 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 189
FIGURE 30 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021) 189
11.1.3 ILLUMINA, INC. 192
TABLE 214 ILLUMINA, INC.: BUSINESS OVERVIEW 192
FIGURE 31 ILLUMINA, INC.: COMPANY SNAPSHOT (2021) 193
11.1.4 PERKINELMER, INC. 198
TABLE 215 PERKINELMER, INC.: BUSINESS OVERVIEW 198
FIGURE 32 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 199
11.1.5 NEOGENOMICS LABORATORIES 202
TABLE 216 NEOGENOMICS LABORATORIES: BUSINESS OVERVIEW 202
FIGURE 33 NEOGENOMICS LABORATORIES: COMPANY SNAPSHOT (2021) 202
11.1.6 QIAGEN N.V. 204
TABLE 217 QIAGEN N.V.: BUSINESS OVERVIEW 204
FIGURE 34 QIAGEN N.V.: COMPANY SNAPSHOT (2021) 205
11.1.7 SOURCE BIOSCIENCE 208
TABLE 218 SOURCE BIOSCIENCE: BUSINESS OVERVIEW 208
FIGURE 35 SOURCE BIOSCIENCE: COMPANY SNAPSHOT (2021) 209
11.1.8 AGILENT TECHNOLOGIES, INC. 210
TABLE 219 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 210
FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021) 210
11.1.9 DNASTAR 213
TABLE 220 DNASTAR: BUSINESS OVERVIEW 213
11.1.10 PSOMAGEN, INC. (FORMERLY MACROGEN CORP.) 215
TABLE 221 PSOMAGEN, INC.: BUSINESS OVERVIEW 215
11.2 OTHER PLAYERS 217
11.2.1 WATERS CORPORATION 217
11.2.2 MICROSYNTH 218
11.2.3 GENEWIZ (A BROOKS LIFE SCIENCES COMPANY) 218
11.2.4 MEDGENOME LABS LTD. 219
11.2.5 PARTEK 219
11.2.6 BEIJING GENOMICS INSTITUTE (BGI) 220
11.2.7 BIOMAX INFORMATICS AG 221
11.2.8 SOPHIA GENETICS 222
11.2.9 FIOS GENOMICS 223
11.2.10 GENUITY SCIENCE (FORMERLY WUXI NEXTCODE) 224
11.2.11 PETDX 225
11.2.12 JADBIO 225
11.2.13 BIOSYSTEMS IMMUNOLAB PLC. 226
11.2.14 ASTALAKE BIOSYSTEMS 226
11.2.15 NUCLEOME INFORMATICS PVT. LTD. 227
*Details on Business overview, Products & services offered, Recent developments, MnM view, Right to win, Strategic choices made, and weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 228
12.1 DISCUSSION GUIDE 228
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 232
12.3 CUSTOMIZATION OPTIONS 234
12.4 RELATED REPORTS 234
12.5 AUTHOR DETAILS 235


    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com